Financial reports
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
29 Mar 22
10-Q
2021 Q3
Quarterly report
10 Nov 21
10-Q
2021 Q2
Quarterly report
12 Aug 21
10-Q
2021 Q1
Quarterly report
13 May 21
10-K
2020 FY
Annual report
25 Mar 21
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 Jun 23
8-K
Bankruptcy or Receivership
5 Jun 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 May 23
8-K
Other Events
16 May 23
8-K
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
10 May 23
8-K
Other Events
25 Apr 23
8-K
Departure of Directors or Certain Officers
3 Feb 23
8-K
HTG Announces Certain Preliminary 2022
6 Jan 23
8-K
Other Events
29 Dec 22
8-K
HTG Molecular Diagnostics Announces Pricing of a
23 Dec 22
Registration and prospectus
25-NSE
Exchange delisting
10 Jul 23
424B4
Prospectus supplement with pricing info
22 Dec 22
POS EX
Additional exhibits for listing
21 Dec 22
S-1/A
IPO registration (amended)
21 Dec 22
S-1
IPO registration
6 Dec 22
S-3
Shelf registration
8 Apr 22
D
$20.88M in equity / options / securities to be acquired, sold $7.5M, 1 investor
25 Mar 22
S-3
Shelf registration
27 Jan 22
S-8
Registration of securities for employees
20 Aug 21
424B5
Prospectus supplement for primary offering
25 Mar 21
Proxies
DEFA14A
Additional proxy soliciting materials
17 Nov 22
DEF 14A
Definitive proxy
31 Oct 22
PRE 14A
Preliminary proxy
21 Oct 22
DEFA14A
Additional proxy soliciting materials
31 Aug 22
DEFA14A
Additional proxy soliciting materials
18 Aug 22
DEFA14A
Additional proxy soliciting materials
7 Jul 22
DEF 14A
Definitive proxy
7 Jul 22
PRE 14A
Preliminary proxy
27 Jun 22
DEFA14A
Additional proxy soliciting materials
7 Jul 21
DEF 14A
Definitive proxy
7 Jul 21
Other
EFFECT
Notice of effectiveness
22 Dec 22
CORRESP
Correspondence with SEC
21 Dec 22
CORRESP
Correspondence with SEC
21 Dec 22
CORRESP
Correspondence with SEC
21 Dec 22
CORRESP
Correspondence with SEC
20 Dec 22
UPLOAD
Letter from SEC
20 Dec 22
UPLOAD
Letter from SEC
16 Dec 22
EFFECT
Notice of effectiveness
20 Apr 22
CORRESP
Correspondence with SEC
15 Apr 22
UPLOAD
Letter from SEC
14 Apr 22
Ownership
4
Stephen Barat
9 Jun 23
4
Stephen Barat
7 Apr 23
SC 13G/A
LYTTON LAURENCE W
13 Feb 23
3
Stephen Barat
10 Feb 23
SC 13G/A
Samjo Capital LLC
10 Feb 23
SC 13G
Cowen Prime Advisors LLC
3 Feb 23
4
Byron Lawson
13 Dec 22
4
John L Lubniewski
13 Dec 22
4
Shaun D McMeans
13 Dec 22
4
Laura Lee Godlewski
13 Dec 22